A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atumelnant in Adult Participants With Classic Congenital Adrenal Hyperplasia (Calm-CAH)

Protocol No
ENDO-CRINETICS-CALM-CAH
Staff Member
Catherine Zhang
Phase
III
Summary

This project is being done to test an investigational new drug called atumelnant. Its purpose is to test the safety and how well atumelnant works compared to placebo.
Objective
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
Status
OPEN TO ACCRUAL
Categories
Diabetes and Endocrinology
ClinicalTrials.gov
https://www.clinicaltrials.gov/study/NCT07144163